Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins that contain 50% or more than 50% of short-acting insulin. This review describes the clinical pharmacology of high-mix insulins, including data from randomized controlled trials. It suggests various ways, in which high-mix insulin can be used, including once daily, twice daily, thrice daily, hetero-mix, and reverse regimes. The authors provide a rational framework to help diabetes care professionals, identify indications for pragmatic high-mix use.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566356 | PMC |
http://dx.doi.org/10.4103/2230-8210.163214 | DOI Listing |
J Assoc Physicians India
April 2019
Departmentof Endocrinology, Bharti Hospital Karnal, Karnal, Haryana; *Corresponding Author.
Objective: Widely used in the management of diabetes, insulin therapy is influenced by several patient preferences and physician choices. This article reports the findings of the IMPACT survey, designed to assess insights on various factors which influence the choice of insulin therapy in India.
Methods: We administered a questionnaire which focused on the practice and patient profiles and the preferred regimens in specific clinical situations using a case scenario.
Diabetes Ther
April 2017
Department of Endocrinology and Metabolism, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Simotsugagun, Tochigi, 321-0293, Japan.
Introduction: Patients with type 2 diabetes, who live in Asian countries, often use premixed insulin analogs. However, if these solutions are insufficiently mixed prior to use, patients will receive inaccurate doses of intermediate- and/or short-acting insulin, which could affect diabetes control. This study aimed to determine whether insulin users were correctly resuspending premixed insulin analog solutions prior to use.
View Article and Find Full Text PDFIndian J Endocrinol Metab
October 2015
Tawam Medical Campus, Johns Hopkins Medicine, Dubai, United Arab Emirates ; Faculty of Medicine, UAE University, Al Ain, Abu Dhabi, United Arab Emirates.
Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins that contain 50% or more than 50% of short-acting insulin.
View Article and Find Full Text PDFDiabetes Obes Metab
July 2009
Institute of Cellular Medicine - Diabetes, Newcastle University, UK.
Objective: To compare blood glucose control when using biphasic insulin aspart (BIAsp) three times a day (using 70/30 high-mix before breakfast and lunch), with biphasic human insulin (BHI, 30/70) twice daily in adults with type 2 diabetes already treated with insulin.
Research Design And Methods: In a 60-day, open-label, crossover study, people with insulin-treated type 2 diabetes [n = 38, baseline haemoglobin A1c 8.3 +/- 0.
Diabetes Obes Metab
July 2009
Dipartimento di Medicina Interna, Policlinico Universitario, Via Consolare Valeria, Messina 1 98124, Italy.
Aim: To evaluate clinical efficacy and safety of biphasic insulin aspart (BIAsp) 30 twice daily (b.i.d.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!